UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 32

Sortiert nach

Attention-based multi-label neural networks for integrated prediction and interpretation of twelve widely occurring RNA modifications

Nature communications, 2021-06, Vol.12 (1), p.4011-4011, Article 4011

2021

Volltextzugriff (PDF)

Predict Epitranscriptome Targets and Regulatory Functions of N6-Methyladenosine (m6A) Writers and Erasers

Evolutionary bioinformatics online, 2019-01, Vol.15

2019

Volltextzugriff (PDF)

Multi-task adaptive pooling enabled synergetic learning of RNA modification across tissue, type and species from low-resolution epitranscriptomes

Briefings in bioinformatics, 2023-05, Vol.24 (3)

2023

Volltextzugriff (PDF)

Predict Epitranscriptome Targets and Regulatory Functions of N 6 -Methyladenosine (m 6 A) Writers and Erasers

Evolutionary bioinformatics online, 2019-01, Vol.15, p.117693431987129-1176934319871290

2019

Volltextzugriff (PDF)

Predict Epitranscriptome Targets and Regulatory Functions of -Methyladenosine (mA) Writers and Erasers

Evolutionary bioinformatics online, 2019-09, Vol.15

2019

Volltextzugriff (PDF)

Prediction of m6A Reader Substrate Sites Using Deep Convolutional and Recurrent Neural Network

The Fifth International Conference on Biological Information and Biomedical Engineering, 2021, p.1-4

2021

Volltextzugriff (PDF)

High-throughput synthesis of binary Al–Mn alloys by directed energy deposition with improved accuracy of composition adjustment

Journal of materials science, 2024-06, Vol.59 (22), p.10022-10034

2024

Volltextzugriff (PDF)

Evaluation of energy performance and environmental benefits for transcritical CO2 thermal system in high-speed trains

Journal of cleaner production, 2024-08, Vol.468, p.143027, Article 143027

2024

Volltextzugriff (PDF)

Rational assessment and selection of air source heat pump system operating with CO2 and R407C for electric bus

Renewable energy, 2022-01, Vol.182, p.86-101

2022

Volltextzugriff (PDF)

Patients’ Preference for Physician Attire in the Internal Medicine Outpatient Department

BioMed research international, 2023, Vol.2023 (1), p.2992888-2992888

2023

Volltextzugriff (PDF)

A subset of gastric cancers with EGFR amplification and overexpression respond to cetuximab therapy

Scientific reports, 2013-10, Vol.3 (1), p.2992, Article 2992

2013

Volltextzugriff (PDF)

P1167: TREATMENT OF RELAPSED/REFRACTORY HGBCL WITH MYC REARRANGEMENT: A MULTICENTER, OPEN‐LABEL, PHASE 2 STUDY OF PC‐002(SEPB)，A FIRST‐IN‐CLASS INHIBITOR OF DEUBIQUITINASES TARGETING MYC DEGRADATION

HemaSphere, 2023-08, Vol.7 (S3), p.e5826880-n/a

2023

Volltextzugriff (PDF)

Overcoming erlotinib resistance with tailored treatment regimen in patient‐derived xenografts from naïve Asian NSCLC patients

International journal of cancer, 2013-01, Vol.132 (2), p.E74-E84

2013

Volltextzugriff (PDF)

Abstract 5630: Treatments of NSCLC-PDX with c-MET gene amplification by c-MET inhibitors lead to rapid development of drug resistance

Cancer research (Chicago, Ill.), 2013-04, Vol.73 (8_Supplement), p.5630-5630

2013

Volltextzugriff (PDF)

Abstract 1322: Autocrine c-met/HGF HCC patient derived xenograft (PDX) models for evaluating c-met inhibitors

Cancer research (Chicago, Ill.), 2012-04, Vol.72 (8_Supplement), p.1322-1322

2012

Volltextzugriff (PDF)

Abstract 2344: PDX from the naïve NSCLC patients containing activating EGFR mutations are resistant to erlotinib but sensitive to c-met inhibitor

Cancer research (Chicago, Ill.), 2012-04, Vol.72 (8_Supplement), p.2344-2344

2012

Volltextzugriff (PDF)

Abstract C113: Modeling cetuximab clinical trial by conducting in vivo efficacy evaluation in large panel CRC patient-derived xenograft (PDX) models

Molecular cancer therapeutics, 2011-11, Vol.10 (11_Supplement), p.C113-C113

2011

Volltextzugriff (PDF)

Abstract 337: A NSCLC PDX with EML4-ALK fusion mutation responds to crizotinib

Cancer research (Chicago, Ill.), 2013-04, Vol.73 (8_Supplement), p.337-337

2013

Volltextzugriff (PDF)

Abstract 2731: Classification of HCC patient derived xenograft (PDX) models by transcriptome and microRNome profiling, and their resemblance to patients

Cancer research (Chicago, Ill.), 2013-04, Vol.73 (8_Supplement), p.2731-2731

2013

Volltextzugriff (PDF)

Abstract 2667: Molecular profiling guided human PDX tumor model selection for preclinical drug evaluation

Cancer research (Chicago, Ill.), 2012-04, Vol.72 (8_Supplement), p.2667-2667

2012

Volltextzugriff (PDF)

Abstract B36: Exploring potential clinical application of cetuximab in NSCLC: Efficacy study in a large panel patient derived xenograft (PDX) model

Molecular cancer therapeutics, 2011-11, Vol.10 (11_Supplement), p.B36-B36

2011

Volltextzugriff (PDF)

Abstract C9: Response to cetuximab is associated with EGFR gene amplification in gastric cancinoma patient derived xenograft models

Molecular cancer therapeutics, 2011-11, Vol.10 (11_Supplement), p.C9-C9

2011

Volltextzugriff (PDF)

Abstract B43: A subset of gastric cancers with EGFR amplification and overexpression respond to cetuximab therapy

Molecular cancer therapeutics, 2013-11, Vol.12 (11_Supplement), p.B43-B43

2013

Volltextzugriff (PDF)

Abstract 1611: Hepatocellular carcinoma xenograft models and biomarkers are powerful tools for the evaluation of the new drugs targeting HCC

Cancer research (Chicago, Ill.), 2011-04, Vol.71 (8_Supplement), p.1611-1611

2011

Volltextzugriff (PDF)

Abstract 4299: CD150, A predictor for xenotransplantation of acute lymphoblastic leukemia to NOD/SCID mice

Cancer research (Chicago, Ill.), 2011-04, Vol.71 (8_Supplement), p.4299-4299

2011

Volltextzugriff (PDF)

1 – 25 von 32

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(30)
Mit Volltextzugriff
(32)

Publikationsform

Artikel
(30)
Tagungsberichte
(2)

Sprache

Englisch
(32)

Erscheinungsjahr

n.n

Thema

Science & Technology
(9)
Life Sciences & Biomedicine
(5)
Science & Technology - Other Topics
(4)
Humans
(3)
Technology
(3)
Animals
(2)
Antineoplastic Agents - Pharmacology
(2)
Cetuximab
(2)
Deep Learning
(2)
Female
(2)
Gene Amplification
(2)
Gene Expression
(2)
Genomes
(2)
Green & Sustainable Science & Technology
(2)
Mathematical & Computational Biology
(2)
Methylation
(2)
Mice
(2)
Multidisciplinary Sciences
(2)
Mutation
(2)
N6-Methyladenosine
(2)

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

Attention-based multi-label neural networks for integrated prediction and interpretation of twelve widely occurring RNA modifications

Predict Epitranscriptome Targets and Regulatory Functions of N6-Methyladenosine (m6A) Writers and Erasers

Multi-task adaptive pooling enabled synergetic learning of RNA modification across tissue, type and species from low-resolution epitranscriptomes

Predict Epitranscriptome Targets and Regulatory Functions of N 6 -Methyladenosine (m 6 A) Writers and Erasers

Predict Epitranscriptome Targets and Regulatory Functions of -Methyladenosine (mA) Writers and Erasers

Prediction of m6A Reader Substrate Sites Using Deep Convolutional and Recurrent Neural Network

High-throughput synthesis of binary Al–Mn alloys by directed energy deposition with improved accuracy of composition adjustment

Evaluation of energy performance and environmental benefits for transcritical CO2 thermal system in high-speed trains

Rational assessment and selection of air source heat pump system operating with CO2 and R407C for electric bus

Patients’ Preference for Physician Attire in the Internal Medicine Outpatient Department

A subset of gastric cancers with EGFR amplification and overexpression respond to cetuximab therapy

P1167: TREATMENT OF RELAPSED/REFRACTORY HGBCL WITH MYC REARRANGEMENT: A MULTICENTER, OPEN‐LABEL, PHASE 2 STUDY OF PC‐002(SEPB)，A FIRST‐IN‐CLASS INHIBITOR OF DEUBIQUITINASES TARGETING MYC DEGRADATION

Overcoming erlotinib resistance with tailored treatment regimen in patient‐derived xenografts from naïve Asian NSCLC patients

Abstract 5630: Treatments of NSCLC-PDX with c-MET gene amplification by c-MET inhibitors lead to rapid development of drug resistance

Abstract 1322: Autocrine c-met/HGF HCC patient derived xenograft (PDX) models for evaluating c-met inhibitors

Abstract 2344: PDX from the naïve NSCLC patients containing activating EGFR mutations are resistant to erlotinib but sensitive to c-met inhibitor

Abstract C113: Modeling cetuximab clinical trial by conducting in vivo efficacy evaluation in large panel CRC patient-derived xenograft (PDX) models

Abstract 337: A NSCLC PDX with EML4-ALK fusion mutation responds to crizotinib

Abstract 2731: Classification of HCC patient derived xenograft (PDX) models by transcriptome and microRNome profiling, and their resemblance to patients

Abstract 2667: Molecular profiling guided human PDX tumor model selection for preclinical drug evaluation

Abstract B36: Exploring potential clinical application of cetuximab in NSCLC: Efficacy study in a large panel patient derived xenograft (PDX) model

Abstract C9: Response to cetuximab is associated with EGFR gene amplification in gastric cancinoma patient derived xenograft models

Abstract B43: A subset of gastric cancers with EGFR amplification and overexpression respond to cetuximab therapy

Abstract 1611: Hepatocellular carcinoma xenograft models and biomarkers are powerful tools for the evaluation of the new drugs targeting HCC

Abstract 4299: CD150, A predictor for xenotransplantation of acute lymphoblastic leukemia to NOD/SCID mice

Suchergebnisse filtern